Furthermore, in subjects with long COVID-19 and post-acute neurological complications, anxiety and depression were significantly associated with higher serum glial reactivity, marked by elevated neuroglial GFAP and Neurofilament Light Polypeptide (NFL) scores [87]. Here, GFAP is linked to depressive symptom measurement.